Viewing Study NCT02289456

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:16 PM

Ignite Modification Date: 2026-02-22 @ 4:53 PM

Study NCT ID: NCT02289456

Status: COMPLETED

Last Update Posted: 2018-12-07

First Post: 2014-11-10

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for First Line Treatment of NSCLC Subjects With ECOG PS 2

Sponsor: Celgene

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module